Costello Asset Management’s Avanos Medical AVNS Stock Holding History

Costello Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-234	Closed	-$2.86K	–	666
2025 Q2	$2.86K	Hold	234	–	–	﹤0.01%	609
2025 Q1	$3.35K	Hold	234	–	–	﹤0.01%	578
2024 Q4	$3.73K	Hold	234	–	–	﹤0.01%	172
2024 Q3	$5.62K	Hold	234	–	–	﹤0.01%	166
2024 Q2	$4.66K	Hold	234	–	–	﹤0.01%	150
2024 Q1	$4.66K	Hold	234	–	–	﹤0.01%	160
2023 Q4	$5.25K	Hold	234	–	–	﹤0.01%	156
2023 Q3	$4.73K	Hold	234	–	–	﹤0.01%	162
2023 Q2	$5.98K	Hold	234	–	–	0.01%	157
2023 Q1	$6.96K	Hold	234	–	–	0.01%	164
2022 Q4	$6.33K	Hold	234	–	–	0.01%	165
2022 Q3	$5K	Hold	234	–	–	﹤0.01%	172
2022 Q2	$6K	Hold	234	–	–	0.01%	178
2022 Q1	$8K	Hold	234	–	–	0.01%	178
2021 Q4	$8K	Hold	234	–	–	﹤0.01%	177
2021 Q3	$7K	Hold	234	–	–	﹤0.01%	180
2021 Q2	$9K	Hold	234	–	–	0.01%	179
2021 Q1	$10K	Hold	234	–	–	0.01%	192
2020 Q4	$11K	Hold	234	–	–	0.01%	174
2020 Q3	$8K	Hold	234	–	–	0.01%	174
2020 Q2	$7K	Buy	+234	New	+$6.77K	0.01%	173

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Costello Asset Management's AVNS Position: Q3 2025 in Review

Costello Asset Management sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 234 shares — an estimated $2.86K sold.

Costello Asset Management first reported a position in AVNS in Q2 2020 and held it in 21 quarters. The position peaked at $11K in Q4 2020. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

Costello Asset Management reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
Costello Asset Management sold 234 Avanos Medical shares in Q3 2025, an estimated $2.86K.
Costello Asset Management first reported a position in Avanos Medical in Q2 2020 and held it in 21 quarters.
Costello Asset Management's Avanos Medical position peaked at $11K in Q4 2020.
276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Costello Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.